Journal article
Prescription Drug Monitoring Program: Access in the First Year
The American journal on addictions, v 30(4), pp 376-381
Jul 2021
PMID: 33760317
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Background and Objectives
Prescription Drug Monitoring Programs (PDMP) detect high‐risk prescribing and patient behaviors. This study describes the characteristics associated with documented PDMP access when prescribing opioids.
Methods
Retrospective chart review of 695 opioid prescriptions written from inpatient and outpatient medical and psychiatric settings. Data were ed and analyzed to identify characteristics associated with documented PDMP access.
Results
One‐third of the charts had PDMP access documented within the week of opioid prescription; 12% showed PDMP consultation on the same day. Services varied greatly from 10.5% (inpatient medicine) to 57% (inpatient psychiatry) with regard to same‐day PDMP access (P < .0001). Patient characteristics associated with PDMP access include having acute pain, current mental health treatment, and current and past substance use disorders (all P < .05). Logistic regression modeling identified three variables associated with the odds of PDMP access (c‐statistic = 0.66): if the prescription originated from the inpatient medicine unit (odds ratio [OR] = 0.47, 95% confidence interval [CI] = 0.32, 0.68), or if the patient received a prescription for an opioid in the past 30 days (OR = 0.30, 95% CI = 0.10, 0.90) or had a urine toxicology screen in the past year (OR = 2.00, 95% CI = 1.40, 2.90).
Discussion and Conclusions
Utilization of the PDMP varied by specialty and setting.
Scientific Significance
This study is among the first to compare rates of PDMP access in a large sample by specialty and practice setting in a healthcare system with a policy requiring its access and appropriate documentation. With less than one‐third adherence to the policy, additional steps to increase consistent PDMP access are warranted. (Am J Addict 2021;00:00–00)
Metrics
Details
- Title
- Prescription Drug Monitoring Program: Access in the First Year
- Creators
- Mitchell Crawford - Harvard UniversityPantea Farahmand - Boston UniversityErin Kate McShane - VA Boston Healthcare SystemAbigail Z. Schein - VA Boston Healthcare SystemJanet Richmond - Tufts UniversityGrace Chang - Harvard University
- Publication Details
- The American journal on addictions, v 30(4), pp 376-381
- Publisher
- Wiley
- Number of pages
- 6
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Psychiatry
- Web of Science ID
- WOS:000631930300001
- Scopus ID
- 2-s2.0-85103205586
- Other Identifier
- 991021889836804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Substance Abuse